AI-driven precision diagnosis and treatment of prostate cancer: a narrative review - Takeaways - MDSpire

AI-driven precision diagnosis and treatment of prostate cancer: a narrative review

  • By

  • Tonghui Chu

  • Youzhao Zhang

  • Jianuo Du

  • Abudurexiti Mierxiati

  • July 16, 2026

Share

  • 1

    Prostate cancer is among the most common cancers in men, with 1.5 million new cases and 397,000 deaths reported globally in 2022.

  • 2

    AI technologies enhance the diagnosis and treatment of prostate cancer by integrating imaging, pathological, and clinical data for improved accuracy.

  • 3

    AI models have shown clinical value in detecting, staging, and grading prostate cancer, but most remain unused in practical clinical settings.

  • 4

    AI assists in surgical procedures, radiation therapy, and drug development, optimizing treatment plans and identifying biomarkers.

  • 5

    The review aims to summarize AI applications in prostate cancer and promote its integration into clinical practice for better patient outcomes.

Original Source(s)

Related Content